Healthcare-associated Infectious Disease Diagnostics Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Urinary Tract Infections Hospitals, Surgical Site Infections, Hospital-acquired Pneumonia, Blood Stream Infections, Other Healthcare-associated Infections), By Applications (Hospitals, Specialty Orthopedic and Spine Centers, ASCs), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Healthcare-associated Infectious Disease Diagnostics Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Healthcare-associated Infectious Disease Diagnostics Business Mode and Production Process
2.3.1 Healthcare-associated Infectious Disease Diagnostics Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Healthcare-associated Infectious Disease Diagnostics Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Healthcare-associated Infectious Disease Diagnostics
2.4.2 Raw Material Cost of Healthcare-associated Infectious Disease Diagnostics
2.4.3 Labor Cost of Healthcare-associated Infectious Disease Diagnostics
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Healthcare-associated Infectious Disease Diagnostics Price by Manufacturer (2021-2026)
4.4 Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Healthcare-associated Infectious Disease Diagnostics, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Healthcare-associated Infectious Disease Diagnostics, Product Offered and Application
4.7 Healthcare-associated Infectious Disease Diagnostics Market Competitive Situation and Trends
4.7.1 Healthcare-associated Infectious Disease Diagnostics Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Healthcare-associated Infectious Disease Diagnostics Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Healthcare-associated Infectious Disease Diagnostics Market Historical Development by Geographic Region (2021-2026)
5.1 Global Healthcare-associated Infectious Disease Diagnostics Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Healthcare-associated Infectious Disease Diagnostics Market Status by Country (2021-2026)
5.3.1 North America Healthcare-associated Infectious Disease Diagnostics Sales Volume by Country (2021-2026)
5.3.2 North America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2021-2026)
5.3.3 United States Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Status by Country (2021-2026)
5.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Sales Volume by Country (2021-2026)
5.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2021-2026)
5.4.3 Germany Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Status by Country (2021-2026)
5.5.1 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2021-2026)
5.5.3 China Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Healthcare-associated Infectious Disease Diagnostics Market Status by Country (2021-2026)
5.6.1 Latin America Healthcare-associated Infectious Disease Diagnostics Sales Volume by Country (2021-2026)
5.6.2 Latin America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2021-2026)
5.6.3 Mexico Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2021-2026)
5.7.3 GCC Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue and Growth (2021-2026)

6 Global Healthcare-associated Infectious Disease Diagnostics Market Historical Development by Product Type (2021-2026)
6.1 Healthcare-associated Infectious Disease Diagnostics Definition by Type
6.2 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume by Product Type (2021-2026)
6.3 Global Healthcare-associated Infectious Disease Diagnostics Historical Revenue by Product Type (2021-2026)
6.4 Global Healthcare-associated Infectious Disease Diagnostics Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Urinary Tract Infections Hospitals (2021-2026)
6.5.2 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Surgical Site Infections (2021-2026)
6.5.3 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hospital-acquired Pneumonia (2021-2026)
6.5.4 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Blood Stream Infections (2021-2026)
6.5.5 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Other Healthcare-associated Infections (2021-2026)

7 Global Healthcare-associated Infectious Disease Diagnostics Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume by End User (2021-2026)
7.3 Global Healthcare-associated Infectious Disease Diagnostics Historical Revenue by End User (2021-2026)
7.4 Global Healthcare-associated Infectious Disease Diagnostics Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of Specialty Orthopedic and Spine Centers (2021-2026)
7.5.3 Global Healthcare-associated Infectious Disease Diagnostics Historical Sales Volume, Revenue and Growth Rate of ASCs (2021-2026)

8 Leading Companies Profiles
8.1 BD
8.1.1 BD Corporation Information
8.1.2 BD - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.1.3 BD Performance Analysis (2021-2026)
8.1.4 BD Business and Markets Served
8.1.5 BD Recent Developments
8.2 OpGen
8.2.1 OpGen Corporation Information
8.2.2 OpGen - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.2.3 OpGen Performance Analysis (2021-2026)
8.2.4 OpGen Business and Markets Served
8.2.5 OpGen Recent Developments
8.3 QIAGEN
8.3.1 QIAGEN Corporation Information
8.3.2 QIAGEN - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.3.3 QIAGEN Performance Analysis (2021-2026)
8.3.4 QIAGEN Business and Markets Served
8.3.5 QIAGEN Recent Developments
8.4 Danaher
8.4.1 Danaher Corporation Information
8.4.2 Danaher - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.4.3 Danaher Performance Analysis (2021-2026)
8.4.4 Danaher Business and Markets Served
8.4.5 Danaher Recent Developments
8.5 Luminex
8.5.1 Luminex Corporation Information
8.5.2 Luminex - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.5.3 Luminex Performance Analysis (2021-2026)
8.5.4 Luminex Business and Markets Served
8.5.5 Luminex Recent Developments
8.6 Trinity Biotech
8.6.1 Trinity Biotech Corporation Information
8.6.2 Trinity Biotech - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.6.3 Trinity Biotech Performance Analysis (2021-2026)
8.6.4 Trinity Biotech Business and Markets Served
8.6.5 Trinity Biotech Recent Developments
8.7 Bio-Rad
8.7.1 Bio-Rad Corporation Information
8.7.2 Bio-Rad - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.7.3 Bio-Rad Performance Analysis (2021-2026)
8.7.4 Bio-Rad Business and Markets Served
8.7.5 Bio-Rad Recent Developments
8.8 Accelerate Diagnostics
8.8.1 Accelerate Diagnostics Corporation Information
8.8.2 Accelerate Diagnostics - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.8.3 Accelerate Diagnostics Performance Analysis (2021-2026)
8.8.4 Accelerate Diagnostics Business and Markets Served
8.8.5 Accelerate Diagnostics Recent Developments
8.9 Thermo Fisher Scientific
8.9.1 Thermo Fisher Scientific Corporation Information
8.9.2 Thermo Fisher Scientific - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.9.3 Thermo Fisher Scientific Performance Analysis (2021-2026)
8.9.4 Thermo Fisher Scientific Business and Markets Served
8.9.5 Thermo Fisher Scientific Recent Developments
8.10 bioMrieux
8.10.1 bioMrieux Corporation Information
8.10.2 bioMrieux - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.10.3 bioMrieux Performance Analysis (2021-2026)
8.10.4 bioMrieux Business and Markets Served
8.10.5 bioMrieux Recent Developments
8.11 Quidel
8.11.1 Quidel Corporation Information
8.11.2 Quidel - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.11.3 Quidel Performance Analysis (2021-2026)
8.11.4 Quidel Business and Markets Served
8.11.5 Quidel Recent Developments
8.12 Abbott
8.12.1 Abbott Corporation Information
8.12.2 Abbott - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.12.3 Abbott Performance Analysis (2021-2026)
8.12.4 Abbott Business and Markets Served
8.12.5 Abbott Recent Developments
8.13 DiaSorin Molecular
8.13.1 DiaSorin Molecular Corporation Information
8.13.2 DiaSorin Molecular - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.13.3 DiaSorin Molecular Performance Analysis (2021-2026)
8.13.4 DiaSorin Molecular Business and Markets Served
8.13.5 DiaSorin Molecular Recent Developments
8.14 Meridian Bioscience
8.14.1 Meridian Bioscience Corporation Information
8.14.2 Meridian Bioscience - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.14.3 Meridian Bioscience Performance Analysis (2021-2026)
8.14.4 Meridian Bioscience Business and Markets Served
8.14.5 Meridian Bioscience Recent Developments
8.15 F. Hoffmann-La Roche
8.15.1 F. Hoffmann-La Roche Corporation Information
8.15.2 F. Hoffmann-La Roche - Healthcare-associated Infectious Disease Diagnostics Product Portfolio and Specification
8.15.3 F. Hoffmann-La Roche Performance Analysis (2021-2026)
8.15.4 F. Hoffmann-La Roche Business and Markets Served
8.15.5 F. Hoffmann-La Roche Recent Developments

9 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by Product Type and End User (2026-2035)
9.1 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by Product Type (2026-2035)
9.1.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Urinary Tract Infections Hospitals (2026-2035)
9.1.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Surgical Site Infections (2026-2035)
9.1.3 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hospital-acquired Pneumonia (2026-2035)
9.1.4 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Blood Stream Infections (2026-2035)
9.1.5 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Other Healthcare-associated Infections (2026-2035)
9.2 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by End User (2026-2035)
9.2.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2035)
9.2.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Specialty Orthopedic and Spine Centers (2026-2035)
9.2.3 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth Rate of ASCs (2026-2035)

10 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by Geographic Region (2026-2035)
10.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Healthcare-associated Infectious Disease Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer